In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12

REED, L. J., & Muench, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 20,341 · see citing works

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Ferraro, M. J. (2000) · Cited by 16,875 · see citing works

A simple method of estimating 50 per cent end points

Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,377 · see citing works

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Liu, C., Bayer, A. S., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,211 · see citing works

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : Approved standard

Wikler, M. A., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 2,842 · see citing works

Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: <i>Endorsed by the Infectious Diseases Society of America</i>

Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707 · see citing works

Automated minimization of steric clashes in protein structures

Ramachandran, S., Kota, P. B., Ding, F., & Dokholyan, N. V. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22879 · Cited by 725 · see citing works

Antibiotic Treatment of Adults With Infective Endocarditis Due to Streptococci, Enterococci, Staphylococci, and HACEK Microorganisms

Wilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492 · see citing works

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association

Wilson, W. R. (1995) · JAMA · doi:10.1001/jama.274.21.1706 · Cited by 289 · see citing works

Impact of High-Inoculum <i>Staphylococcus aureus</i> on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model

LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284 · see citing works

Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.

Murray, B. E., & Mederski-Samaroj, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111042 · Cited by 256 · see citing works

Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function

Murray, B. E., Singh, K. V., Ross, R. P., Heath, J. D., Dunny, G. M., & Weinstock, G. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.16.5216-5223.1993 · Cited by 203 · see citing works

Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?

Paul, M., Zemer‐Wassercug, N., Talker, O., Lishtzinsky, Y., Lev, B., Samra, Z., Leibovici, L., & Bishara, J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03425.x · Cited by 187 · see citing works

Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program

Figueroa, D. A., Mangini, E., Amodio-Groton, M. I., Vardianos, B., MELCHERT, A., Fana, C., Wehbeh, W., Urban, C. M., & Segal‐Maurer, S. (2009) · Clinical Infectious Diseases · doi:10.1086/600039 · Cited by 153 · see citing works

Importance of the Collagen Adhesin Ace in Pathogenesis and Protection against Enterococcus faecalis Experimental Endocarditis

Singh, K. V., Nallapareddy, S. R., Sillanpää, J., & Murray, B. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000716 · Cited by 148 · see citing works

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus : Frequency and Possible Cause of Cefazolin Treatment Failure

Nannini, E. C., Stryjewski, M. E., Singh, K. V., Bourgogne, A., Rude, T. H., Corey, G. R., Fowler, V. G., & Murray, B. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-09 · Cited by 148 · see citing works

Efficacy of Daptomycin in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

Sakoulas, G., Eliopoulos, G. M., Alder, J. D., & Eliopoulos, C. T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1714-1718.2003 · Cited by 134 · see citing works

Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?

Lee, S., Choe, P. G., Song, K., Park, S., Kim, H. B., Kim, N. J., Kim, E.-C., Park, W. B., & Oh, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00485-11 · Cited by 128 · see citing works

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin

Lamp, K. C., Rybak, M. J., Bailey, E. M., & Kaatz, G. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2709 · Cited by 124 · see citing works

Elimination of Plasmids from Several Bacterial Species by Novobiocin

McHugh, G., & Swartz, M. N. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.3.423 · Cited by 110 · see citing works

Characterization of the staphylococcal beta‐lactamase transposon Tn552.

Rowland, S. J., & Dyke, K. G. H. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08418.x · Cited by 108 · see citing works

Characterization of four beta-lactamases produced by Staphylococcus aureus

Zygmunt, D. J., Stratton, C. W., & Kernodle, D. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.440 · Cited by 103 · see citing works

Real-Time In Vivo Bioluminescent Imaging for Evaluating the Efficacy of Antibiotics in a Rat Staphylococcus aureus Endocarditis Model

Xiong, Y. Q., Willard, J., Kadurugamuwa, J. L., Yu, J., Francis, K. P., & Bayer, A. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.380-387.2005 · Cited by 103 · see citing works

Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics

Zuluaga, A. F., Agudelo, M., Rodríguez, C. A., & Vesga, Ó. (2009) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-9-1 · Cited by 100 · see citing works

CEFAZOLIN, A NEW SEMISYNTHETIC CEPHALOSPORIN ANTIBIOTIC. I

Kariyone, K., Harada, H., Kurita, M., & Takano, T. (1970) · The Journal of Antibiotics · doi:10.7164/antibiotics.23.131 · Cited by 93 · see citing works

Identification and Characterization of the Multidrug Resistance Gene cfr in a Panton-Valentine Leukocidin-Positive Sequence Type 8 Methicillin-Resistant Staphylococcus aureus IVa (USA300) Isolate

Shore, A. C., Brennan, O. M., Ehricht, R., Monecke, S., Schwarz, Š., Slickers, P., & Coleman, D. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-10 · Cited by 93 · see citing works

BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis

Entenza, J. M., Hohl, P., Heinze‐Krauss, I., Glauser, M. P., & Moreillon, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.171-177.2002 · Cited by 92 · see citing works

Unsuccessful Treatment of Staphylococcal Endocarditis With Cefazolin

Bryant, R. E. (1977) · JAMA · doi:10.1001/jama.1977.03270330059022 · Cited by 87 · see citing works

Differentiation of -Lactamase Variants of Staphylococcus aureus by Substrate Hydrolysis Profiles

Kernodle, D. S., Stratton, C. W., Mcmurray, L. W., Chipley, J. R., & McGraw, P. A. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.1.103 · Cited by 72 · see citing works

Clinical Experiences with Cefazolin and Other Cephalosporins in Bacterial Endocarditis

Quinn, E. L., Pohlod, D. J., Madhavan, T., Burch, K., Fisher, E. J., & Cox, F. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_2.s386 · Cited by 68 · see citing works

Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis

García-de-la-Mària, C., Marco, F., Armero, Y., Soy, D., Moreno, A., del Rı́o, A., Almela, M., Cervera, C., Ninot, S. P. I., Falces, C., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-09 · Cited by 68 · see citing works

Linezolid Therapy of Staphylococcus aureus Experimental Osteomyelitis

Patel, R., Piper, K. E., Rouse, M. S., & Steckelberg, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3438-3440.2000 · Cited by 60 · see citing works

Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals

Rincón, S., Reyes, J., Carvajal, L. P., Rojas, N., Cortés-Muñoz, F., Panesso, D., Guzman, M., Zurita, J., Adachi, J. A., Murray, B. E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt254 · Cited by 58 · see citing works

Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

Marco, F., de la Mària, C. G., Armero, Y., Amat, E., Soy, D., Moreno, A., del Rı́o, A., Almela, M., Mestres, C. A., Gatell, J. M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00510-07 · Cited by 58 · see citing works

Nucleotide sequence and expression of the beta-lactamase gene from Staphylococcus aureus plasmid pI258 in Escherichia coli, Bacillus subtilis, and Staphylococcus aureus

Wang, P.-Z., & Novick, R. P. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.4.1763-1766.1987 · Cited by 57 · see citing works

Prevalence of blaZ Gene Types and the Inoculum Effect with Cefazolin among Bloodstream Isolates of Methicillin-Susceptible Staphylococcus aureus

Livorsi, D. J., Crispell, E. K., Satola, S. W., Burd, E. M., Jerris, R. C., Wang, Y. F., & Farley, M. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00052-12 · Cited by 56 · see citing works

Characterization of a Chromosomal Gene Encoding Type B β-Lactamase in Phage Group II Isolates of Staphylococcus aureus

Voladri, R. K. R., & Kernodle, D. S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3163 · Cited by 56 · see citing works

Constitutive Penicillinase Formation in Staphylococcus aureus Owing to a Mutation Unlinked to the Penicillinase Plasmid

Cohen, S., & Sweeney, H. M. (1968) · Journal of Bacteriology · doi:10.1128/jb.95.4.1368-1374.1968 · Cited by 54 · see citing works

Comparative Pharmacokinetics of Ceforanide (BL-S786R) and Cefazolin in Laboratory Animals and Humans

Lee, F. H., Pfeffer, M., Harken, D. R. V., Smyth, R. D., & Hottendorf, G. H. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.2.188 · Cited by 54 · see citing works

Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants

Kernodle, D. S., McGraw, P. A., Stratton, C. W., & Kaiser, A. B. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.3.420 · Cited by 53 · see citing works

Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

Murillo, Ó., Garrigós, C., Pachón, M. E., Euba, G., Verdaguer, R., Cabellos, C., Cabo, J., Gudiol, F., & Ariza, J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00208-09 · Cited by 52 · see citing works

Physical mapping of Staphylococcus aureus penicillinase plasmid pI524: Characterization of an invertible region

Murphy, E., & Novick, R. P. (1979) · Molecular and General Genetics MGG · doi:10.1007/bf00267851 · Cited by 48 · see citing works

Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus

Tattevin, P., Basuino, L., Bauer, D. C., Diep, B. A., & Chambers, H. F. “. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00886-09 · Cited by 39 · see citing works

Rapid Analysis of Cefazolin in Serum by High-Pressure Liquid Chromatography

Wold, J. S. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.1.105 · Cited by 38 · see citing works

Cefazolin Therapy for Staphylococcus aureus Bacteremia

Fernández-Guerrero, M. L., & Górgolas, M. (2005) · Clinical Infectious Diseases · doi:10.1086/430833 · Cited by 36 · see citing works

Importance of -Lactamase Inactivation in Treatment of Experimental Endocarditis Caused by Staphylococcus aureus

Goldman, P. L., & Petersdorf, R. G. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/141.3.331 · Cited by 36 · see citing works

Nucleotide sequence of theStaphylococcus aureusPCI β-lactamase gene

Chan, P. T. K. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.14.5940 · Cited by 36 · see citing works

Staphylococcal -Lactamase and Efficacy of -Lactam Antibiotics: In Vitro and in Vivo Evaluation

Chapman, S. W., & Steigbigel, R. T. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.6.1078 · Cited by 34 · see citing works

Evidence of incorporation of the chromosomal beta-lactamase gene of Enterococcus faecalis CH19 into a transposon derived from staphylococci

Rice, L. B., & Marshall, S. H. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1843 · Cited by 29 · see citing works

Change of a single amino acid in the leader peptide of a staphylococcal β-lactamase prevents the appearance of the enzyme in the medium

East, A. K. (1990) · FEMS Microbiology Letters · doi:10.1016/0378-1097(90)90075-2 · Cited by 16 · see citing works

Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.

Kozatani, J., Okui, M., Matsubara, T., & Nishida, M. (1972) · PubMed · Cited by 15 · see citing works

[6] Immunological techniques for studying β-lactamases

Richmond, M. H. (1975) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(75)43082-8 · Cited by 14 · see citing works

Cefazolin versus cephalothin in β-lactamase-producing Staphylococcus aureus endocarditis in a rabbit experimental model

Carrizosa, J., Kobasa, W. D., Snepar, R., Kaye, K. M., & Kaye, D. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/9.5.387 · Cited by 13 · see citing works

Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats

Catherall, E. J., Gillon, V., Hurn, S. E., Irwin, R., & Mizen, L. W. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.2.458 · Cited by 11 · see citing works

CEFAZOLIN, A NEW SEMISYNTHETIC CEPHALOSPORIN ANTIBIOTIC. VI

Kozatani, J., Okui, M., Matsubara, T., & Nishida, M. (1972) · The Journal of Antibiotics · doi:10.7164/antibiotics.25.86 · Cited by 8 · see citing works

Mechanisms of Antibiotic Resistance

Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782 · see citing works

Mechanisms of antibiotic resistance

Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421 · see citing works

Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability

Sharma, S. S., Chauhan, A. P. S., Ranjan, A., Mathkor, D. M., Haque, S., Ramniwas, S., Tuli, H. S., Jindal, T., & Yadav, V. K. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1403168 · Cited by 227 · see citing works

Inoculum effect of β-lactam antibiotics

Lenhard, J. R., & Bulman, Z. P. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz226 · Cited by 159 · see citing works

Evolving Resistance Among Gram-positive Pathogens

Munita, J. M., Bayer, A. S., & Arias, C. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ523 · Cited by 134 · see citing works

Comparison of Cefazolin versus Oxacillin for Treatment of Complicated Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus

Li, J., Echevarria, K. L., Hughes, D. W., Cadena, J. A., Bowling, J. E., & Lewis, J. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02800-14 · Cited by 117 · see citing works

The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia

Miller, W. R., Seas, C., Carvajal, L. P., Díaz, L., Echeverri, A. M., Ferro, C., Ríos, R., Porras, P., Luna, C. M., Gotuzzo, E., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy123 · Cited by 108 · see citing works

Inoculum effect of antimicrobial peptides

Loffredo, M. R., Savini, F., Bobone, S., Casciaro, B., Franzyk, H., Mangoni, M. L., & Stella, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014364118 · Cited by 104 · see citing works

Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design

Ndagi, U., Falaki, A. A., Abdullahi, M., Lawal, M. M., & Soliman, M. E. S. (2020) · RSC Advances · doi:10.1039/d0ra01484b · Cited by 78 · see citing works

Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review

Loubet, P., Burdet, C., Vindrios, W., Grall, N., Wolff, M., Yazdanpanah, Y., Andremont, A., Duval, X., & Lescure, F.-X. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.07.003 · Cited by 66 · see citing works

Clinical Implications of Cefazolin Inoculum Effect and β-Lactamase Type on Methicillin-Susceptible Staphylococcus aureus Bacteremia

Lee, S., Kwon, K. T., Kim, H. I., Chang, H., Lee, J., Choe, P. G., Park, W. B., Kim, N. J., Oh, M., Song, D. Y., et al. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0229 · Cited by 60 · see citing works

Rationale for Eliminating Staphylococcus Breakpoints for -Lactam Agents Other Than Penicillin, Oxacillin or Cefoxitin, and Ceftaroline

Bard, J. D., Hindler, J. A., Gold, H. S., & Limbago, B. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu043 · Cited by 59 · see citing works

Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia

Ulloa, E. R., Singh, K. V., Geriak, M., Haddad, F. A., Murray, B. E., Nizet, V., & Sakoulas, G. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz995 · Cited by 54 · see citing works

Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia

Sakoulas, G., Olson, J., Yim, J., Singh, N. B., Kumaraswamy, M., Quach, D., Rybak, M. J., Pogliano, J. A., & Nizet, V. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01192-16 · Cited by 53 · see citing works

Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center

Pollett, S., Baxi, S. M., Rutherford, G. W., Doernberg, S. B., Bacchetti, P., & Chambers, H. F. “. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00243-16 · Cited by 50 · see citing works

β‐Lactam Therapy for Methicillin‐Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins

Li, J., Echevarria, K. L., & Traugott, K. A. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1892 · Cited by 49 · see citing works

Application of antimicrobial peptides in plant protection: making use of the overlooked merits

Tang, R., Tan, H. M., Dai, Y., Li, L., Huang, Y., Yao, H., Cai, Y., & Yu, G. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1139539 · Cited by 50 · see citing works

Therapeutic Phage Monitoring: A Review

Bosco, K., Lynch, S. A., Sandaradura, I., & Khatami, A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad497 · Cited by 36 · see citing works

Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children

McNeil, J. C., Sommer, L. M., Boyle, M., Hogan, P. G., Vallejo, J. G., Hultén, K. G., Flores, A. R., Kaplan, S. L., & Fritz, S. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00703-20 · Cited by 35 · see citing works

Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort

the Korea INfectious Diseases (KIND) study group, Song, K., Jung, S., Lee, S., Park, S., Kiem, S., Lee, S. H., Kwak, Y.-G., Ys, K., Jang, H.-C., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2799-1 · Cited by 34 · see citing works

Effects of cefazolin-containing niosome nanoparticles against methicillin-resistant Staphylococcus aureus biofilm formed on chronic wounds

Zafari, M., Adibi, M., Chiani, M., Bolourchi, N., Barzi, S. M., Nosrati, M. S. S., Bahari, Z., Shirvani, P., Noghabi, K. A., Ebadi, M., et al. (2020) · Biomedical Materials · doi:10.1088/1748-605x/abc7f2 · Cited by 33 · see citing works

β-Lactam Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis

Jean, B., Crolle, M., Pollani, C., Guilloux, A. L., Martin‐Blondel, G., Tattevin, P., Bot, A. L., Paz, D. L., Guérin, F., Cattoir, V., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.51353 · Cited by 32 · see citing works

Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study

Lecomte, R., Bourreau, A., Deschanvres, C., Issa, N., Turnier, P. L., Gaborit, B. J., Chauveau, M., Leroy, A., Tourneau, T. L., Caillon, J., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.044 · Cited by 30 · see citing works

A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections

Miller, M. A., Fish, D. N., Barber, G. R., Barron, M. A., Goolsby, T. A., Moine, P., & Mueller, S. W. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.07.006 · Cited by 28 · see citing works

Significant publications on infectious diseases pharmacotherapy in 2015

Babic, J. T., Sofjan, A. K., Babin, M., Echevarria, K. L., Ikwuagwu, J. O., Lam, W.-Y. M., Aitken, S. L., & Perez, K. K. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160090 · Cited by 26 · see citing works

Bistable Bacterial Growth Dynamics in the Presence of Antimicrobial Agents

Frenkel, N., Dover, R. S., Titon, E., Shai, Y., & Rom‐Kedar, V. (2021) · Antibiotics · doi:10.3390/antibiotics10010087 · Cited by 24 · see citing works

Cinnamon and clove oil nanoemulsions: novel therapeutic options against vancomycin intermediate susceptible Staphylococcus aureus

Franklyne, J. S., Ebenazer, L. A., Mukherjee, A., & Chandrasekaran, N. (2019) · Applied Nanoscience · doi:10.1007/s13204-019-01111-4 · Cited by 24 · see citing works

Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams

Saeki, M., Shinagawa, M., Yakuwa, Y., Nirasawa, S., Sato, Y., Yanagihara, N., & Takahashi, S. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.10.021 · Cited by 23 · see citing works

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study

Lefèvre, B., Hoen, B., Goehringer, F., Sime, W. N., Aissa, N., Alauzet, C., Jeanmaire, E., Hénard, S., Filippetti, L., Selton‐Suty, C., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04313-3 · Cited by 21 · see citing works

Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis

Singh, K. V., Tran, T. T., Nannini, E. C., Tam, V. H., Arias, C. A., & Murray, B. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-17 · Cited by 21 · see citing works

In-cell Solid-State NMR Studies of Antimicrobial Peptides

Separovic, F., Keizer, D. W., & Sani, M. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.610203 · Cited by 19 · see citing works

Comparative Efficacies of Cloxacillin-Daptomycin and the Standard Cloxacillin-Rifampin Therapies against an Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus

Haj, C. E., Murillo, Ó., Ribera, A., Vivas, M., García-Somoza, D., Tubau, F., Cabo, J., & Ariza, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02681-14 · Cited by 17 · see citing works

Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: A systematic review and meta-analysis

Vardakas, K. Z., Apiranthiti, K. N., & Falagas, M. E. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.09.002 · Cited by 16 · see citing works

Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis

Castañeda, X., García-de-la-Mària, C., Gasch, O., Pericàs, J. M., Soy, D., Cañas-Pacheco, M. A., Falces, C., García‐González, J., Hernández‐Meneses, M., Vidal, B., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab069 · Cited by 15 · see citing works

The Cefazolin Inoculum Effect and the Presence of type A blaZ Gene according to agr Genotype in Methicillin-Susceptible Staphylococcus aureus Bacteremia

Lee, S. O., Lee, S., Park, S., Lee, J. E., & Lee, S. H. (2019) · Infection and Chemotherapy · doi:10.3947/ic.2019.51.4.376 · Cited by 13 · see citing works

Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus

Lee, S. H., Park, W. B., Lee, S., Park, S., Kim, S., Lee, J., Chang, H., Kwon, K. T., Choe, P. G., Kim, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01517-16 · Cited by 13 · see citing works

Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae

Golikova, M. V., Strukova, E. N., Натиговна, А. К., Андреевич, А. В., Александровна, А. А., Sulian, O. S., & Zinner, S. H. (2023) · Antibiotics · doi:10.3390/antibiotics12050872 · Cited by 11 · see citing works

Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis

Miller, W. R., Singh, K. V., Arias, C. A., & Murray, B. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01158-18 · Cited by 11 · see citing works

Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group

Yavuz, S. Ş. (2020) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2020.01954 · Cited by 10 · see citing works

The Application of Rat Models in Staphylococcus aureus Infections

Liang, H., Wang, Y., Liu, F., Duan, G., Long, J., Jin, Y., Chen, S., & Yang, H. (2024) · Pathogens · doi:10.3390/pathogens13060434 · Cited by 8 · see citing works

Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Narrative Review

Chastain, D. B., Covert, K. L., Tu, P. J., McDougal, S., White, B. P., & Cluck, D. B. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231158809 · Cited by 8 · see citing works

Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?

Karchmer, A. W. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix288 · Cited by 8 · see citing works

Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort

Calderón‐Parra, J., Grillo, S., Muñóz, P., Machado-Vílchez, M., Delgado-Montero, A., de Alarcón, A., Borrego, M. P., Goenaga-Sánchez, M. Á., Fariñas, M. C., Miró, J. M., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106352 · Cited by 7 · see citing works

Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study

Forsblom, E., Ruotsalainen, E., & Järvinen, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167112 · Cited by 7 · see citing works

In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin

Lee, S. O., Lee, J. E., Park, S., Lee, J. E., & Lee, S. H. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf065 · Cited by 6 · see citing works

Effectiveness and safety of cefazolin versus cloxacillin in endocarditis due to methicillin-susceptible Staphylococcus spp.: a multicenter propensity weighted cohort study

Destrem, A.-L., Maillard, A., Simonet, M., Siméon, S., Contejean, A., Vignau, C., Pires, L., Isnard, M., Vitrat, V., Delory, T., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04851-6 · Cited by 6 · see citing works

Enhanced Killing of Methicillin-Resistant Staphylococcus aureus With Ceftaroline or Vancomycin in Combination With Carbapenems

Jankeel, A., Pérez-Parra, G., Khetarpal, A. K., Alvarado, I., Nizet, V., Sakoulas, G., & Ulloa, E. R. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf010 · Cited by 6 · see citing works

Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model

Singh, K. V., Arias, C. A., & Murray, B. E. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02303-19 · Cited by 6 · see citing works

Cefazolin pharmacokinetics in cats under surgical conditions

Albarellos, G., Montoya, L., Passini, S. M., Lupi, M. P., Lorenzini, P. M., & Landoni, M. F. (2016) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x16666594 · Cited by 6 · see citing works

Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect

Strukova, E. N., Golikova, M. V., Анатольевна, Д. С., Борисович, К. М., & Zinner, S. H. (2023) · Antibiotics · doi:10.3390/antibiotics12121705 · Cited by 5 · see citing works

Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections

Chan, L., Chan-Tompkins, N. H., Como, J., & Guarascio, A. J. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019897267 · Cited by 5 · see citing works

Evaluation of Daptomycin Use in Outpatients With Methicillin-Sensitive Staphylococcus aureus Bloodstream Infections

Kener, D., Childress, D. T., Andrus, I., Olson, J. A., & Webb, B. J. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf012 · Cited by 4 · see citing works

Efficacy of Telavancin Alone and in Combination with Ampicillin in a Rat Model of Enterococcus faecalis Endocarditis

Tran, T. T., Tam, V. H., Murray, B. E., Arias, C. A., & Singh, K. V. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02489-16 · Cited by 4 · see citing works

Antibacterial Agents

Sauberan, J. B., Neely, M. N., & Bradley, J. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00292-5 · Cited by 3 · see citing works

Genome Sequence Comparison of Staphylococcus aureus TX0117 and a Beta-Lactamase-Cured Derivative Shows Increased Cationic Peptide Resistance Accompanying Mutations in relA and mnaA

Sales, M. J., Sakoulas, G., Szubin, R., Palsson, B. Ø., Arias, C. A., Singh, K. V., Murray, B. E., & Monk, J. M. (2020) · Microbiology Resource Announcements · doi:10.1128/mra.01515-19 · Cited by 3 · see citing works

Disc Test for Detecting Staphylococcus aureus Strains Producing Type A and Type C β-Lactamases

George, C. R. R., Lahra, M. M., Nguyen, T., & Gatus, B. J. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00220-23 · Cited by 2 · see citing works

Céfazoline : une alternative à la cloxacilline ?

Potel, G., Montassier, E., & Batard, É. (2016) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2016.09.001

Hurdles to managing a case of methicillin-susceptible Staphylococcus aureus: A clinical nightmare

Philips, G. M., & Bhattacharjee, S. (2020) · International Journal of Academic Medicine · doi:10.4103/ijam.ijam_24_19

Clearance of Persistent Methicillin-Susceptible Staphylococcus lugdunensis Bacteremia Using Nafcillin Plus Ertapenem Combination Therapy

Sharma, I., Hodges, J., Moonah, S. N., & Shirley, D.-A. T. (2023) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001277

A population-based cohort study to establish clinical characteristics and outcomes of patients experiencing methicillin-sensitive Staphylococcus aureus bacteremia as a function of the cefazolin high inoculum effectPreprint

Kipp, A. J., Du, K., Wadell, B., Robinson, S., Svishchuk, J., Conly, J. M., Ulke‐Lemée, A., Mapar, M., Lewis, I. A., Gregson, D. B., et al. (2025) · medRxiv · doi:10.64898/2025.12.03.25341560

Re-examining cephalosporin activity against methicillin-susceptible Staphylococcus aureus among clinical isolates from southern Taiwan

Lin, Y.-T., Kuo, S., Chien, C., Hung, C., Ming, H.-Y., Huang, T.-Y., & Ch, L. (2026) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlag029

Epidémiologie et usage des antibiotiques dans l'endocardite infectieuse : données de l'observatoire national français ObservatoireEI

Lefèvre, B. (2022) · doi:10.70675/0ba26df0zdd78z4577za81czc9c4c6233cb8

Early Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Double Coverage or Double Trouble?

Doernberg, S. B., & Holland, T. L. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag229

Cefazolin Versus Antistaphylococcal Penicillins in Methicillin-Susceptible Staphylococcus aureus Bone and Joint Infections: A Narrative Review

Werneburg, F., Beschauner, J., Werneburg, L. I., Zeh, A., Gutteck, N., & Delank, K.-S. (2026) · Antibiotics · doi:10.3390/antibiotics15090930

Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis

Singh, K. V., Tran, T. T., Nannini, E. C., Tam, V. H., Arias, C. A., & Murray, B. E. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-17 · Cited by 21 · see citing works

Cefazolin plus Clavulanic Acid Overcomes the Inoculum Effect in a Methicillin-Susceptible Staphylococcus aureus (MSSA) Rat Endocarditis Model

Miller, W. A., Singh, K. V., Arias, C. A., & Murray, B. E. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx162.031

Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams

Saeki, M., Shinagawa, M., Yakuwa, Y., Nirasawa, S., Sato, Y., Yanagihara, N., & Takahashi, S. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.10.021 · Cited by 23 · see citing works

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus : Frequency and Possible Cause of Cefazolin Treatment Failure

Nannini, E. C., Stryjewski, M. E., Singh, K. V., Bourgogne, A., Rude, T. H., Corey, G. R., Fowler, V. G., & Murray, B. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-09 · Cited by 148 · see citing works

Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis

Miller, W. R., Singh, K. V., Arias, C. A., & Murray, B. E. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01158-18 · Cited by 11 · see citing works